Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rizzu, P.
Right arrow Articles by Heutink, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzu, P.
Right arrow Articles by Heutink, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 20 3075-3082
© 2000 Oxford University Press

Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients

Patrizia Rizzu1,2, Marijke Joosse1, Rivka Ravid3, Andre Hoogeveen1, Wouter Kamphorst4, John C. van Swieten2, Rob Willemsen1 and Peter Heutink1,+

1Department of Clinical Genetics and 2Department of Neurology, Erasmus University, PO Box 1738, 3000 DR Rotterdam, The Netherlands, 3The Netherlands Brain Bank, 1105 AZ Amsterdam, The Netherlands and 4Department of Pathology, Vrije University 1081 HV Amsterdam, The Netherlands

Mutations in the gene for the microtubule-associated protein tau are associated with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). In this study we compared the presence of the P301L mutated tau protein from brain material of patients with that of the normal 4-repeat, using polyclonal antibodies specific for the P301L point mutation and its normal counterpart. We determined the relative ratio of mutated versus normal tau protein in the sarkosyl-soluble and -insoluble protein fractions from several brain regions. Although mutated and normal tau proteins are both present in the sarkosyl-insoluble deposits, quantitative analysis showed that the mutated protein is the major component. In the sarkosyl-soluble fraction of frontal and temporal cortex the overall ratio of 3-repeat versus 4-repeat tau isoforms is unchanged but there is a dramatic depletion of mutant tau protein. Furthermore, we observed an increase in tau-immunoreactive cleavage products with the P301L antibody, suggesting that the mutant protein is partly resistant to degradation and this is confirmed by pulse–chase experiments. This is the first direct evidence using patient material that shows a selective aggregation of mutant tau protein resulting in sarkosyl-insoluble deposits and the specific depletion of mutated tau protein in the soluble fraction.

+ To whom correspondence should be addressed. Tel: +31 10 408 8136; Fax: +31 10 408 9489; Email: heutink@kgen.fgg.eur.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Aoyagi, M. Hasegawa, and A. Tamaoka
Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau
J. Biol. Chem., July 13, 2007; 282(28): 20309 - 20318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Murakami, E. Paitel, T. Kawarabayashi, M. Ikeda, M. A. Chishti, C. Janus, E. Matsubara, A. Sasaki, T. Kawarai, A. L. Phinney, et al.
Cortical Neuronal and Glial Pathology in TgTauP301L Transgenic Mice: Neuronal Degeneration, Memory Disturbance, and Phenotypic Variation
Am. J. Pathol., October 1, 2006; 169(4): 1365 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
I. F. Bronner, B. C. ter Meulen, A. Azmani, L. A. Severijnen, R. Willemsen, W. Kamphorst, R. Ravid, P. Heutink, and J. C. van Swieten
Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology
Brain, November 1, 2005; 128(11): 2645 - 2653.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. G. Macedo, B. Anar, I. F. Bronner, M. Cannella, F. Squitieri, V. Bonifati, A. Hoogeveen, P. Heutink, and P. Rizzu
The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes
Hum. Mol. Genet., November 1, 2003; 12(21): 2807 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
P. M. Stanford, C. E. Shepherd, G. M. Halliday, W. S. Brooks, P. W. Schofield, H. Brodaty, R. N. Martins, J. B. J. Kwok, and P. R. Schofield
Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia
Brain, April 1, 2003; 126(4): 814 - 826.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Tatebayashi, T. Miyasaka, D.-H. Chui, T. Akagi, K.-i. Mishima, K. Iwasaki, M. Fujiwara, K. Tanemura, M. Murayama, K. Ishiguro, et al.
Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau
PNAS, October 15, 2002; 99(21): 13896 - 13901.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. von Bergen, S. Barghorn, L. Li, A. Marx, J. Biernat, E.-M. Mandelkow, and E. Mandelkow
Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local beta -Structure
J. Biol. Chem., December 14, 2001; 276(51): 48165 - 48174.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.